Role of novel imaging in the management of prostate cancer.

Karen M Xu, Ronald C Chen, David M Schuster, Ashesh B Jani

Journal: Urologic oncology 2020;37(9):611-618

PMID: 31072791

Full Text on Elsevier Science View on PubMed

Abstract

This review summarizes novel imaging in the management of prostate cancer including multiparametric MRI, PET-CT scans with different radiotracers including C-acetate, C-choline, F-choline, F sodium fluoride, prostate-specific membrane antigen, and anti-1-amino-3-[18F] fluorocyclobutane-1-carboxylic acid (fluciclovine).

Address: Department of Radiation Oncology and Winship Cancer Institute of Emory University, Emory University, Atlanta, GA.; Department of Radiation Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Department of Radiology and Imaging Sciences, Division of Nuclear Medicine and Molecular Imaging, Emory University Hospital, Atlanta, GA.; Department of Radiation Oncology and Winship Cancer Institute of Emory University, Emory University, Atlanta, GA. Electronic address: [email protected].

DOI: 10.1016/j.urolonc.2019.04.008

Link outs

Free resources

Medical:

https://medlineplus.gov/prostatecancer.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Male, Prostatic Neoplasms